Electroceuticals Market

Electroceuticals Market / Bioelectric Medicine Market by Product (Cardiac Pacemakers, ICD, Cochlear Implant, Neuromodulation (Deep Brain Stimulation)), Type (Implantable, Non-Invasive), Application (Arrhythmia, Heart Failure, Epilepsy) & Region - Global Forecast to 2029

Report Code: MD 4358 Mar, 2024, by marketsandmarkets.com

The global electroceuticals market in terms of revenue was estimated to be worth $23.9 billion in 2024 and is poised to reach $33.6 billion by 2029, growing at a CAGR of 7.0% from 2024 to 2029. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. In recent years, there has been a rapid advancement in medical technology, leading to significant changes in therapies and medicine. This progress has contributed to the substantial growth of the bioelectric medicine market. The market is expected to be driven by ongoing developments in the healthcare sector and the increasing integration of technology in medical applications.

Attractive Opportunities in the Electroceuticals Market

Electroceuticals  Market

To know about the assumptions considered for the study, Request for Free Sample Report

Electroceuticals  Market

Electroceuticals Market Dynamics

Driver: The increasing elderly population and subsequent rise in the prevalence of neurological and cardiovascular disorder

The geriatric population is more susceptible to developing neurologic or cardiovascular disorders, making them a significant segment of the patient pool. This population segment's growth will drive continued and increased demand for electroceutical devices like cardiac pacemakers, implantable cardioverter defibrillators, deep brain stimulators, and spinal cord stimulators for treating cardiovascular and neurological disorders.

Restraint: The high cost associated with electroceutical devices

The high cost of electroceutical devices like cochlear implants and neurostimulators is a significant factor limiting market growth, especially in price-sensitive regions such as the Asia Pacific, Latin America, and Africa. Healthcare providers in developing countries like Brazil and Mexico often have limited financial resources for investing in advanced technologies. Additionally, extensive training is required for staff to efficiently handle and maintain these devices. Furthermore, the development of technologically advanced electroceutical devices, such as cochlear implants, necessitates extensive R&D efforts, leading to increased manufacturing costs. This requires substantial capital investment, which may only be feasible for established or major players in the market. Moreover, the market is dominated by large, well-established players with high brand loyalty, making it challenging for new entrants to compete unless they can differentiate themselves through innovative product offerings.

Opportunity: Emerging markets present attractive opportunities.

Emerging economies like India, South Korea, Malaysia, Vietnam, various African nations, and Middle Eastern countries such as Israel, Saudi Arabia, and the UAE present substantial growth prospects for major market participants. This is due to their minimal regulatory hurdles, enhancements in healthcare infrastructure, expanding patient bases, and increasing healthcare spending. Moreover, regulatory frameworks in the Asia Pacific region are more flexible and conducive to business compared to developed nations. Consequently, heightened competition in mature markets has prompted leading players in the electroceuticals/bioelectric medicine market to shift their focus toward these emerging economies.

Challenge: The shortage of skilled professionals

The proper placement of electroceutical devices like neurostimulators requires the expertise of neurosurgeons specialized in neural implant procedures, often with a functional neurosurgery fellowship. However, there is currently a significant gap between the demand and supply of such neurologists globally. This shortage is expected to be a concern due to the projected increase in healthcare demand driven by factors such as a growing patient population and rising disease prevalence. One of the major limitations is the challenge of producing an adequate number of trained neurosurgeons within a short timeframe. The scarcity of skilled staff, including neurologists and neurosurgeons, in key regions worldwide is anticipated to have a negative impact on the number of neurosurgery procedures performed each year, affecting the market demand for electroceutical devices like neurostimulators.

Electroceuticals  Market Ecosystem

In 2022, cardiac pacemakers & implantable cardioverter defibrillators accounted for the largest share of the electroceuticals industry, by product

The electroceuticals market is segmented into cardiac pacemakers & implantable cardioverter defibrillators, neuromodulators, cochlear implants, and retinal implants. based on product. The cardiac pacemakers & implantable cardioverter defibrillators segment accounted for the largest share of the bioelectric medicine market in 2022. The segmental growth of the market is driven by the high prevalence of sudden cardiac arrest (SCA), which often leads to arrhythmia and mortality. According to the US Centers for Disease Control and Prevention, over 350,000 people experience out-of-hospital cardiac arrest in the US alone. Electroceuticals are utilized in various applications to prevent and treat cardiac arrest, with cardiac pacemakers and implantable cardioverter defibrillators (ICDs) being used to manage arrhythmia.

In 2022, implantable electroceutical devices segment accounted for the largest share in the electroceuticals industry, by type

The electroceuticals market is segmented into implantable electroceutical devices and non-invasive electroceutical devices based on type. In 2022, implantable devices offer long-lasting effectiveness, precise targeting, and reduce the need for medication. The rising prevalence of chronic diseases and a growing elderly population are expected to drive demand for these devices in the future.

North America is the largest regional market for electroceuticals industry

The global electroceuticals market is segmented into five major regions—North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2022, the North American region emerged as the global leader in the bioelectric medicine market, driven by the presence of numerous major market players and widespread adoption of advanced medical technology. The market in this region is expanding due to a growing focus on technological advancements in the healthcare sector and the increasing prevalence of chronic diseases such as diabetes, cardiovascular disease, hearing loss, and neurological disorders.

Electroceuticals  Market by Region

To know about the assumptions considered for the study, download the pdf brochure

The major players in bioelectric medicine market are Medtronic plc (Ireland), Boston Scientific Corporation (US), Abbott Laboratories, Inc. (US), LivaNova PLC (UK), Cochlear Ltd. (Australia). These players lead the market because of their extensive product portfolios and wide geographic presence. These dominant market players also have numerous advantages, such as more robust marketing and distribution networks, larger budgets for R&D, and better brand recognition.

Scope of the Electroceuticals Industry

Report Metric

Details

Market Revenue in 2024

$23.9 billion

Projected Revenue by 2029

$33.6 billion

Revenue Rate

Poised to Grow at a CAGR of 7.0%

Market Driver

The increasing elderly population and subsequent rise in the prevalence of neurological and cardiovascular disorder

Market Opportunity

Emerging markets present attractive opportunities.

This report categorizes the bioelectric medicine market to forecast revenue and analyze trends in each of the following submarkets:

By Product

  • Cardiac Pacemakers & Implantable Cardioverter Defibrillators
  • Cochlear Implants
  • Neuromodulators
    • Spinal Cord Stimulators
    • Deep Brain Stimulators
    • Sacral Nerve Stimulators
    • Vagus Nerve Stimulators
    • Gastric Electrical Stimulators
    • Transcutaneous Electrical Nerve Stimulator
    • Transcranial Magnetic Stimulators
    • Respiratory Electrical Stimulators
    • Trigeminal Nerve Stimulators
    • Responsive Neurostimulators
  • Retinal Implants

By Type

  • Implantable Electroceutical Devices
  • Non-Invasive Electroceutical Devices

By Application

  • Cardiac Pacemakers & Implantable Cardioverter Defibrillators (ICD), By Application
    • Arrhythmia
    • Heart Failure
    • Other Cardiac Pacemakers & ICD Applications
  • Spinal Cord Stimulators Market, By Application
    • Failed Back Syndrome
    • Chronic Pain
    • Ischemia
  • Deep Brain Stimulators Market, By Application
    • Parkinson’s Disease
    • Tremor
    • Depression
    • Other DBS Applications
  • Sacral Nerve Stimulators Market, By Application
    • Urine Incontinence
    • Fecal Incontinence
  • Vagus Nerve Stimulators Market, By Application
    • Epilepsy
    • Other VNS Applications
  • Gastric Electrical Stimulators Market, By Application
    • Gastroparesis
    • Obesity
  • Transcutaneous Electrical Nerve Stimulators Market, By Application
    • Treatment-Resistant Depression
    • Other TENS Applications
  • Transcranial Magnetic Stimulators Market, By Application
    • Depression
    • Migraine Headache
  • Trigeminal Nerve Stimulators, By Application
    • Attention Deficit Hyperactivity Disorder (ADHD)
    • Migraine

By Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Rest of Asia Pacific
  • Latin America
    • Middle East & Africa
      • GCC Countries
      • Rest of Middle East & Africa

Recent Developments of Electroceuticals Industry:

  • In January 2024, Medtronic plc (Ireland) received FDA approval of its Percept RC Deep Brain Stimulation (DBS) system.
  • In July 2023, Boston Scientific Corporation (US) received the US FDA approval for the vercise neural navigator 5 software, which when used as part of the vercise genus deep brain stimulation (dbs) systems.
  • In May 2023, Abbott (US) received US FDA approval for its spinal cord stimulation (SCS) devices for the treatment of chronic back pain.
  • In Dec 2022, ElectroCore (US) launched a new wellness product offering called Truvaga for customers residing in the US. Truvaga is a handheld non-invasive vagus nerve stimulator that utilizes our proven technology to quickly and gently activate the vagus nerve.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS
 
1 INTRODUCTION (Page No. - 53)
    1.1 STUDY OBJECTIVES 
    1.2 MARKET DEFINITION 
           1.2.1 INCLUSIONS & EXCLUSIONS OF STUDY
    1.3 STUDY SCOPE 
          FIGURE 1 ELECTROCEUTICALS MARKET SEGMENTATION
           1.3.1 GEOGRAPHIC SCOPE
           1.3.2 YEARS CONSIDERED
    1.4 CURRENCY 
    1.5 LIMITATIONS 
    1.6 STAKEHOLDERS 
    1.7 SUMMARY OF CHANGES 
           1.7.1 RECESSION IMPACT
 
2 RESEARCH METHODOLOGY (Page No. - 58)
    2.1 RESEARCH DATA 
          FIGURE 2 RESEARCH DESIGN
           2.1.1 SECONDARY DATA
                    2.1.1.1 Key data from secondary sources
           2.1.2 PRIMARY DATA
                    2.1.2.1 Key data from primary sources
                    2.1.2.2 Key industry insights
                                TABLE 1 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
                                FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
                                FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY END USER, DESIGNATION, AND REGION
    2.2 MARKET SIZE ESTIMATION 
           2.2.1 BOTTOM-UP APPROACH
                    FIGURE 5 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH (COMPANY REVENUE ESTIMATION APPROACH)
                    FIGURE 6 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH (SEGMENTAL REVENUE ESTIMATION APPROACH)
                    FIGURE 7 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
                    FIGURE 8 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
    2.3 MARKET BREAKDOWN & DATA TRIANGULATION 
          FIGURE 9 DATA TRIANGULATION METHODOLOGY
    2.4 MARKET SHARE ANALYSIS 
    2.5 ASSUMPTIONS 
    2.6 RISK ASSESSMENT 
          TABLE 2 RISK ASSESSMENT: BIOELECTRIC MEDICINE MARKET
    2.7 LIMITATIONS 
           2.7.1 METHODOLOGY-RELATED LIMITATIONS
           2.7.2 SCOPE-RELATED LIMITATIONS
    2.8 IMPACT OF RECESSION ON ELECTROCEUTICALS INDUSTRY
 
3 EXECUTIVE SUMMARY (Page No. - 70)
    FIGURE 10 ELECTROCEUTICALS MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION)
    FIGURE 11 BIOELECTRIC MEDICINE MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
    FIGURE 12 ELECTROCEUTICALS INDUSTRY FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
    FIGURE 13 BIOELECTRIC MEDICINE MARKET, BY REGION, 2024 VS. 2029 (USD MILLION)
 
4 PREMIUM INSIGHTS (Page No. - 73)
    4.1 ELECTROCEUTICALS MARKET OVERVIEW 
          FIGURE 14 RISING PREVALENCE OF NEUROLOGICAL AND CARDIOVASCULAR DISORDERS TO DRIVE MARKET
    4.2 ELECTROCEUTICALS INDUSTRY SHARE, BY PRODUCT, 2024 VS. 2029 
          FIGURE 15 CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS WILL CONTINUE TO DOMINATE MARKET IN 2029
    4.3 BIOELECTRIC MEDICINE MARKET SHARE, BY TYPE, 2024 VS. 2029 
          FIGURE 16 IMPLANTABLE ELECTROCEUTICAL DEVICES TO DOMINATE MARKET IN 2024
    4.4 ELECTROCEUTICALS MARKET SHARE FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2024 VS. 2029 
          FIGURE 17 ARRHYTHMIA SEGMENT TO DOMINATE MARKET IN 2029
    4.5 ELECTROCEUTICALS INDUSTRY: GEOGRAPHIC GROWTH OPPORTUNITIES 
          FIGURE 18 ASIA PACIFIC TO REGISTER HIGHEST GROWTH IN BIOELECTRIC MEDICINE MARKET DURING FORECAST PERIOD
 
5 MARKET OVERVIEW (Page No. - 76)
    5.1 INTRODUCTION 
    5.2 MARKET DYNAMICS 
          FIGURE 19 ELECTROCEUTICALS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
           5.2.1 DRIVERS
                    5.2.1.1 Rising geriatric population and subsequent growth in prevalence of neurological and cardiovascular disorders
                    5.2.1.2 Rising government support and funding for neurological disorders
                    5.2.1.3 Increasing investments and funding for research on CRM devices
                    5.2.1.4 Increasing focus on development of advanced neuromodulation and cardiac devices
                    5.2.1.5 Increasing collaborations among device manufacturers, healthcare providers, and research institutes to develop neuromodulation and cardiac devices
                    5.2.1.6 Availability of reimbursements for neuromodulation, cardiac devices, and cochlear implants
                    5.2.1.7 Growing prevalence of hearing loss and increasing adoption of smart hearing aids
           5.2.2 RESTRAINTS
                    5.2.2.1 High cost of electroceutical devices
                    5.2.2.2 Preference for drug therapies over neuromodulation and cardiac products
                    5.2.2.3 Adverse effects and complications associated with neuromodulation, cardiac devices, and cochlear implants
                                TABLE 3 POTENTIAL ADVERSE EFFECTS ASSOCIATED WITH DIFFERENT DEVICES
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Emerging markets
                    5.2.3.2 Development of ICDs and MRI-compatible ICDs and CRT-Ds
                    5.2.3.3 Integration with digital health platforms
           5.2.4 CHALLENGES
                    5.2.4.1 Dearth of trained professionals
                    5.2.4.2 Challenges associated with battery life and device replacement
                    5.2.4.3 Complexity and infection issues related to electroceutical devices
           5.2.5 TRENDS
                    5.2.5.1 Role of artificial intelligence (AI) in electroceutical devices
                    5.2.5.2 Wearable and portable electroceuticals
    5.3 PRICING ANALYSIS 
          TABLE 4 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT (2022)
          TABLE 5 AVERAGE SELLING PRICE TREND FOR NEUROMODULATION DEVICES AND PROCEDURES, BY REGION (2022)
    5.4 VALUE CHAIN ANALYSIS 
          FIGURE 20 VALUE CHAIN ANALYSIS: MAJOR VALUE ADDED DURING MANUFACTURING AND ASSEMBLY PHASES
    5.5 SUPPLY CHAIN ANALYSIS 
          FIGURE 21 DIRECT DISTRIBUTION—PREFERRED STRATEGY FOR PROMINENT COMPANIES
    5.6 ECOSYSTEM ANALYSIS OF ELECTROCEUTICALS MARKET 
          FIGURE 22 BIOELECTRIC MEDICINE MARKET: ECOSYSTEM ANALYSIS
           5.6.1 ROLE IN ECOSYSTEM
                    TABLE 6 ELECTROCEUTICALS INDUSTRY: ROLE IN ECOSYSTEM
           5.6.2 KEY PLAYERS IN BIOELECTRIC MEDICINE MARKET
                    FIGURE 23 ELECTROCEUTICALS MARKET: KEY PLAYERS
    5.7 PORTER’S FIVE FORCES ANALYSIS 
          TABLE 7 ELECTROCEUTICALS INDUSTRY: PORTER’S FIVE FORCES ANALYSIS
           5.7.1 THREAT OF NEW ENTRANTS
           5.7.2 INTENSITY OF COMPETITIVE RIVALRY
           5.7.3 BARGAINING POWER OF BUYERS
           5.7.4 BARGAINING POWER OF SUPPLIERS
           5.7.5 THREAT OF SUBSTITUTES
    5.8 REGULATORY LANDSCAPE 
           5.8.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    TABLE 8 INDICATIVE LIST OF REGULATORY AUTHORITIES GOVERNING BIOELECTRIC MEDICINE MARKET
           5.8.2 NORTH AMERICA
                    5.8.2.1 US
                                TABLE 9 US FDA: MEDICAL DEVICE CLASSIFICATION
                                TABLE 10 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
                    5.8.2.2 Canada
                                TABLE 11 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
           5.8.3 EUROPE
           5.8.4 ASIA PACIFIC
                    5.8.4.1 China
                                TABLE 12 CHINA: CLASSIFICATION OF MEDICAL DEVICES
                    5.8.4.2 Japan
                    5.8.4.3 India
    5.9 TECHNOLOGY ANALYSIS 
    5.10 TRADE ANALYSIS 
           5.10.1 IMPORT SCENARIO FOR PACEMAKERS
                     TABLE 13 IMPORT DATA FOR PACEMAKERS, BY COUNTRY, 2018–2022 (USD MILLION)
           5.10.2 EXPORT SCENARIO FOR PACEMAKERS
                     TABLE 14 EXPORT DATA FOR PACEMAKERS, BY COUNTRY, 2018–2022 (USD MILLION)
           5.10.3 IMPORT SCENARIO FOR COMPLIANT PRODUCTS
                     TABLE 15 IMPORT DATA FOR HS CODE 901890-COMPLIANT PRODUCTS, BY COUNTRY, 2018–2022 (USD MILLION)
           5.10.4 EXPORT SCENARIO FOR COMPLIANT PRODUCTS
                     TABLE 16 EXPORT DATA FOR HS CODE 901890-COMPLIANT PRODUCTS, BY COUNTRY, 2018–2022 (USD MILLION)
    5.11 PATENT ANALYSIS 
           FIGURE 24 ELECTROCEUTICALS MARKET: PATENT ANALYSIS OF CARDIAC PACEMAKERS
           FIGURE 25 ELECTROCEUTICALS INDUSTRY: PATENT ANALYSIS OF NEUROMODULATION PRODUCTS
    5.12 KEY CONFERENCES AND EVENTS 
           TABLE 17 LIST OF CONFERENCES & EVENTS, 2024–2025
    5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS 
           FIGURE 26 REVENUE SHIFT FOR BIOELECTRIC MEDICINE MARKET
    5.14 KEY STAKEHOLDERS AND BUYING CRITERIA 
           5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS
                     FIGURE 27 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS
                     TABLE 18 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY END USER
           5.14.2 BUYING CRITERIA
                     FIGURE 28 KEY BUYING CRITERIA FOR HOSPITALS
 
6 ELECTROCEUTICALS MARKET, BY PRODUCT (Page No. - 104)
    6.1 INTRODUCTION 
          TABLE 19 ELECTROCEUTICALS INDUSTRY, BY PRODUCT, 2021–2029 (USD MILLION)
    6.2 CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS 
           6.2.1 INTRODUCTION OF LEADLESS AND MRI-SAFE PACEMAKERS & DEFIBRILLATORS TO BOOST MARKET GROWTH
                    TABLE 20 KEY PRODUCTS IN CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET
                    TABLE 21 CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2021–2029 (USD MILLION)
                    TABLE 22 NORTH AMERICA: CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
                    TABLE 23 EUROPE: CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
                    TABLE 24 ASIA PACIFIC: CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
                    TABLE 25 MIDDLE EAST & AFRICA: CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2021–2029 (USD MILLION)
    6.3 COCHLEAR IMPLANTS 
           6.3.1 INCREASING PREVALENCE OF HEARING LOSS TO DRIVE DEMAND
                    TABLE 26 KEY PRODUCTS IN COCHLEAR IMPLANTS MARKET
                    TABLE 27 COCHLEAR IMPLANTS MARKET, BY REGION, 2021–2029 (USD MILLION)
                    TABLE 28 NORTH AMERICA: COCHLEAR IMPLANTS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
                    TABLE 29 EUROPE: COCHLEAR IMPLANTS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
                    TABLE 30 ASIA PACIFIC: COCHLEAR IMPLANTS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
                    TABLE 31 MIDDLE EAST & AFRICA: COCHLEAR IMPLANTS MARKET, BY REGION, 2021–2029 (USD MILLION)
    6.4 NEUROMODULATORS 
          TABLE 32 NEUROMODULATORS MARKET, BY TYPE, 2021–2029 (USD MILLION)
          TABLE 33 NEUROMODULATORS MARKET, BY REGION, 2021–2029 (USD MILLION)
          TABLE 34 NORTH AMERICA: NEUROMODULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
          TABLE 35 EUROPE: NEUROMODULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
          TABLE 36 ASIA PACIFIC: NEUROMODULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
          TABLE 37 MIDDLE EAST & AFRICA: NEUROMODULATORS MARKET, BY REGION, 2021–2029 (USD MILLION)
           6.4.1 SPINAL CORD STIMULATORS
                    6.4.1.1 Growing incidence of spinal cord injuries to support market growth
                                TABLE 38 KEY SPINAL CORD STIMULATOR DEVICES AVAILABLE IN MARKET
                                TABLE 39 SPINAL CORD STIMULATORS MARKET, BY REGION, 2021–2029 (USD MILLION)
                                TABLE 40 NORTH AMERICA: SPINAL CORD STIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
                                TABLE 41 EUROPE: SPINAL CORD STIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
                                TABLE 42 ASIA PACIFIC: SPINAL CORD STIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
                                TABLE 43 MIDDLE EAST & AFRICA: SPINAL CORD STIMULATORS MARKET, BY REGION, 2021–2029 (USD MILLION)
           6.4.2 DEEP BRAIN STIMULATORS
                    6.4.2.1 Widely used to control debilitating symptoms caused by movement and neurological disorders
                                TABLE 44 KEY DEEP BRAIN STIMULATOR DEVICES AVAILABLE IN MARKET
                                TABLE 45 DEEP BRAIN STIMULATORS MARKET, BY REGION, 2021–2029 (USD MILLION)
                                TABLE 46 NORTH AMERICA: DEEP BRAIN STIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
                                TABLE 47 EUROPE: DEEP BRAIN STIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
                                TABLE 48 ASIA PACIFIC: DEEP BRAIN STIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
                                TABLE 49 MIDDLE EAST & AFRICA: DEEP BRAIN STIMULATORS MARKET, BY REGION, 2021–2029 (USD MILLION)
           6.4.3 VAGUS NERVE STIMULATORS
                    6.4.3.1 High incidence of epilepsy to drive market
                                TABLE 50 KEY VAGUS NERVE STIMULATOR DEVICES AVAILABLE IN MARKET
                                TABLE 51 VAGUS NERVE STIMULATORS MARKET, BY REGION, 2021–2029 (USD MILLION)
                                TABLE 52 NORTH AMERICA: VAGUS NERVE STIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
                                TABLE 53 EUROPE: VAGUS NERVE STIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
                                TABLE 54 ASIA PACIFIC: VAGUS NERVE STIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
                                TABLE 55 MIDDLE EAST & AFRICA: VAGUS NERVE STIMULATORS MARKET, BY REGION, 2021–2029 (USD MILLION)
           6.4.4 SACRAL NERVE STIMULATORS
                    6.4.4.1 Widening scope of sacral nerve stimulation to drive growth
                                TABLE 56 KEY SACRAL NERVE STIMULATOR DEVICES AVAILABLE IN MARKET
                                TABLE 57 SACRAL NERVE STIMULATORS MARKET, BY REGION, 2021–2029 (USD MILLION)
                                TABLE 58 NORTH AMERICA: SACRAL NERVE STIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
                                TABLE 59 EUROPE: SACRAL NERVE STIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
                                TABLE 60 ASIA PACIFIC: SACRAL NERVE STIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
                                TABLE 61 MIDDLE EAST & AFRICA: SACRAL NERVE STIMULATORS MARKET, BY REGION, 2021–2029 (USD MILLION)
           6.4.5 GASTRIC ELECTRICAL STIMULATORS
                    6.4.5.1 Growing number of people suffering from severe GERD and gastroparesis to fuel market growth
                                TABLE 62 GASTRIC ELECTRICAL STIMULATORS MARKET, BY REGION, 2021–2029 (USD MILLION)
                                TABLE 63 NORTH AMERICA: GASTRIC ELECTRICAL STIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
                                TABLE 64 EUROPE: GASTRIC ELECTRICAL STIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
                                TABLE 65 ASIA PACIFIC: GASTRIC ELECTRICAL STIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
                                TABLE 66 MIDDLE EAST & AFRICA: GASTRIC ELECTRICAL STIMULATORS MARKET, BY REGION, 2021–2029 (USD MILLION)
           6.4.6 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS
                    6.4.6.1 Extensive use in healthcare, low cost, and ease of use to favor market growth
                                TABLE 67 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET, BY REGION, 2021–2029 (USD MILLION)
                                TABLE 68 NORTH AMERICA: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
                                TABLE 69 EUROPE: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
                                TABLE 70 ASIA PACIFIC: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
                                TABLE 71 MIDDLE EAST & AFRICA: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET, BY REGION, 2021–2029 (USD MILLION)
           6.4.7 TRANSCRANIAL MAGNETIC STIMULATORS
                    6.4.7.1 Minimal patient discomfort associated with TMS to support demand
                                TABLE 72 TRANSCRANIAL MAGNETIC STIMULATORS MARKET, BY REGION, 2021–2029 (USD MILLION)
                                TABLE 73 NORTH AMERICA: TRANSCRANIAL MAGNETIC STIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
                                TABLE 74 EUROPE: TRANSCRANIAL MAGNETIC STIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
                                TABLE 75 ASIA PACIFIC: TRANSCRANIAL MAGNETIC STIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
                                TABLE 76 MIDDLE EAST & AFRICA: TRANSCRANIAL MAGNETIC STIMULATORS MARKET, BY REGION, 2021–2029 (USD MILLION)
           6.4.8 RESPIRATORY ELECTRICAL STIMULATORS
                    6.4.8.1 Increasing incidence of spinal cord injuries to drive market
                                TABLE 77 RESPIRATORY ELECTRICAL STIMULATORS MARKET, BY REGION, 2021–2029 (USD MILLION)
                                TABLE 78 NORTH AMERICA: RESPIRATORY ELECTRICAL STIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
                                TABLE 79 EUROPE: RESPIRATORY ELECTRICAL STIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
                                TABLE 80 ASIA PACIFIC: RESPIRATORY ELECTRICAL STIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
                                TABLE 81 MIDDLE EAST & AFRICA: RESPIRATORY ELECTRICAL STIMULATORS MARKET, BY REGION, 2021–2029 (USD MILLION)
           6.4.9 TRIGEMINAL NERVE STIMULATORS
                    6.4.9.1 High treatment efficacy to fuel market growth
                                TABLE 82 TRIGEMINAL NERVE STIMULATORS MARKET, BY REGION, 2021–2029 (USD MILLION)
                                TABLE 83 NORTH AMERICA: TRIGEMINAL NERVE STIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
                                TABLE 84 EUROPE: TRIGEMINAL NERVE STIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
                                TABLE 85 ASIA PACIFIC: TRIGEMINAL NERVE STIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
                                TABLE 86 MIDDLE EAST & AFRICA: TRIGEMINAL NERVE STIMULATORS MARKET, BY REGION, 2021–2029 (USD MILLION)
           6.4.10 RESPONSIVE NEUROSTIMULATORS
                    6.4.10.1 Targeted and personalized treatment to fuel market growth
                                TABLE 87 RESPONSIVE NEUROSTIMULATORS MARKET, BY REGION, 2021–2029 (USD MILLION)
                                TABLE 88 NORTH AMERICA: RESPONSIVE NEUROSTIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
                                TABLE 89 EUROPE: RESPONSIVE NEUROSTIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
                                TABLE 90 ASIA PACIFIC: RESPONSIVE NEUROSTIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
                                TABLE 91 MIDDLE EAST & AFRICA: RESPONSIVE NEUROSTIMULATORS MARKET, BY REGION, 2021–2029 (USD MILLION)
    6.5 RETINAL IMPLANTS 
           6.5.1 GROWING NUMBER OF RETINITIS PIGMENTOSA CASES TO SUPPORT MARKET GROWTH
                    TABLE 92 RETINAL IMPLANTS MARKET, BY REGION, 2021–2029 (USD MILLION)
                    TABLE 93 NORTH AMERICA: RETINAL IMPLANTS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
                    TABLE 94 EUROPE: RETINAL IMPLANTS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
                    TABLE 95 ASIA PACIFIC: RETINAL IMPLANTS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
                    TABLE 96 MIDDLE EAST & AFRICA: RETINAL IMPLANTS MARKET, BY REGION, 2021–2029 (USD MILLION)
 
7 ELECTROCEUTICALS MARKET, BY TYPE (Page No. - 151)
    7.1 INTRODUCTION 
          TABLE 97 ELECTROCEUTICALS INDUSTRY, BY TYPE, 2021–2029 (USD MILLION)
    7.2 IMPLANTABLE ELECTROCEUTICAL DEVICES 
           7.2.1 LONG-TERM COST SAVINGS TO DRIVE MARKET
                    TABLE 98 IMPLANTABLE ELECTROCEUTICAL DEVICES MARKET, BY REGION, 2021–2029 (USD MILLION)
                    TABLE 99 NORTH AMERICA: IMPLANTABLE ELECTROCEUTICAL DEVICES MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
                    TABLE 100 EUROPE: IMPLANTABLE ELECTROCEUTICAL DEVICES MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
                    TABLE 101 ASIA PACIFIC: IMPLANTABLE ELECTROCEUTICAL DEVICES MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
                    TABLE 102 MIDDLE EAST & AFRICA: IMPLANTABLE ELECTROCEUTICAL DEVICES MARKET, BY REGION, 2021–2029 (USD MILLION)
    7.3 NONINVASIVE ELECTROCEUTICAL DEVICES 
           7.3.1 EXTENSIVE USE IN HEALTHCARE, EASE OF USE, AND LOW COST TO SUPPORT MARKET GROWTH
                    TABLE 103 NONINVASIVE ELECTROCEUTICAL DEVICES MARKET, BY REGION, 2021–2029 (USD MILLION)
                    TABLE 104 NORTH AMERICA: NONINVASIVE ELECTROCEUTICAL DEVICES MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
                    TABLE 105 EUROPE: NONINVASIVE ELECTROCEUTICAL DEVICES MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
                    TABLE 106 ASIA PACIFIC: NONINVASIVE ELECTROCEUTICAL DEVICES MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
                    TABLE 107 MIDDLE EAST & AFRICA: NONINVASIVE ELECTROCEUTICAL DEVICES MARKET, BY REGION, 2021–2029 (USD MILLION)
 
8 ELECTROCEUTICALS MARKET, BY APPLICATION (Page No. - 160)
    8.1 INTRODUCTION 
    8.2 ELECTROCEUTICALS INDUSTRY FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD), BY APPLICATION 
          TABLE 108 BIOELECTRIC MEDICINE MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021–2029 (USD MILLION)
           8.2.1 ARRHYTHMIA
                    8.2.1.1 Increasing prevalence of arrhythmia to support market growth
                                TABLE 109 CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET FOR ARRHYTHMIA, BY REGION, 2021–2029 (USD MILLION)
                                TABLE 110 NORTH AMERICA: CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET FOR ARRHYTHMIA, BY COUNTRY, 2021–2029 (USD MILLION)
                                TABLE 111 EUROPE: CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET FOR ARRHYTHMIA, BY COUNTRY, 2021–2029 (USD MILLION)
                                TABLE 112 ASIA PACIFIC: CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET FOR ARRHYTHMIA, BY COUNTRY, 2021–2029 (USD MILLION)
           8.2.2 HEART FAILURE
                    8.2.2.1 Rising prevalence of heart-related conditions in older individuals to drive growth
                                TABLE 113 CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET FOR HEART FAILURE, BY REGION, 2021–2029 (USD MILLION)
                                TABLE 114 NORTH AMERICA: CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET FOR HEART FAILURE, BY COUNTRY, 2021–2029 (USD MILLION)
                                TABLE 115 EUROPE: CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET FOR HEART FAILURE, BY COUNTRY, 2021–2029 (USD MILLION)
                                TABLE 116 ASIA PACIFIC: CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET FOR HEART FAILURE, BY COUNTRY, 2021–2029 (USD MILLION)
           8.2.3 OTHER CARDIAC PACEMAKER & ICD APPLICATIONS
                    TABLE 117 CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET FOR OTHER APPLICATIONS, BY REGION, 2021–2029 (USD MILLION)
                    TABLE 118 NORTH AMERICA: CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2029 (USD MILLION)
                    TABLE 119 EUROPE: CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2029 (USD MILLION)
                    TABLE 120 ASIA PACIFIC: CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2029 (USD MILLION)
    8.3 ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION 
          TABLE 121 BIOELECTRIC MEDICINE MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
           8.3.1 CHRONIC PAIN
                    8.3.1.1 High incidence of chronic pain to support market growth
                                TABLE 122 SPINAL CORD STIMULATORS MARKET FOR CHRONIC PAIN, BY REGION, 2021–2029 (USD MILLION)
                                TABLE 123 NORTH AMERICA: SPINAL CORD STIMULATORS MARKET FOR CHRONIC PAIN, BY COUNTRY, 2021–2029 (USD MILLION)
                                TABLE 124 EUROPE: SPINAL CORD STIMULATORS MARKET FOR CHRONIC PAIN, BY COUNTRY, 2021–2029 (USD MILLION)
                                TABLE 125 ASIA PACIFIC: SPINAL CORD STIMULATORS MARKET FOR CHRONIC PAIN, BY COUNTRY, 2021–2029 (USD MILLION)
           8.3.2 FAILED BACK SURGERY SYNDROME
                    8.3.2.1 Increasing incidence of FBSS to drive demand
                                TABLE 126 SPINAL CORD STIMULATORS MARKET FOR FAILED BACK SURGERY SYNDROME, BY REGION, 2021–2029 (USD MILLION)
                                TABLE 127 NORTH AMERICA: SPINAL CORD STIMULATORS MARKET FOR FAILED BACK SURGERY SYNDROME, BY COUNTRY, 2021–2029 (USD MILLION)
                                TABLE 128 EUROPE: SPINAL CORD STIMULATORS MARKET FOR FAILED BACK SURGERY SYNDROME, BY COUNTRY, 2021–2029 (USD MILLION)
                                TABLE 129 ASIA PACIFIC: SPINAL CORD STIMULATORS MARKET FOR FAILED BACK SURGERY SYNDROME, BY COUNTRY, 2021–2029 (USD MILLION)
           8.3.3 ISCHEMIA
                    8.3.3.1 High effectiveness of neuromodulation for ischemia treatment to propel market
                                TABLE 130 SPINAL CORD STIMULATORS MARKET FOR ISCHEMIA, BY REGION, 2021–2029 (USD MILLION)
                                TABLE 131 NORTH AMERICA: SPINAL CORD STIMULATORS MARKET FOR ISCHEMIA, BY COUNTRY, 2021–2029 (USD MILLION)
                                TABLE 132 EUROPE: SPINAL CORD STIMULATORS MARKET FOR ISCHEMIA, BY COUNTRY, 2021–2029 (USD MILLION)
                                TABLE 133 ASIA PACIFIC: SPINAL CORD STIMULATORS MARKET FOR ISCHEMIA, BY COUNTRY, 2021–2029 (USD MILLION)
    8.4 BIOELECTRIC MEDICINE MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION 
          TABLE 134 BIOELECTRIC MEDICINE MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
           8.4.1 PARKINSON’S DISEASE
                    8.4.1.1 Rising incidence of Parkinson’s disease and growing R&D to drive market
                                TABLE 135 DEEP BRAIN STIMULATORS MARKET FOR PARKINSON’S DISEASE, BY REGION, 2021–2029 (USD MILLION)
                                TABLE 136 NORTH AMERICA: DEEP BRAIN STIMULATORS MARKET FOR PARKINSON’S DISEASE, BY COUNTRY, 2021–2029 (USD MILLION)
                                TABLE 137 EUROPE: DEEP BRAIN STIMULATORS MARKET FOR PARKINSON’S DISEASE, BY COUNTRY, 2021–2029 (USD MILLION)
                                TABLE 138 ASIA PACIFIC: DEEP BRAIN STIMULATORS MARKET FOR PARKINSON’S DISEASE, BY COUNTRY, 2021–2029 (USD MILLION)
           8.4.2 TREMORS
                    8.4.2.1 High efficacy of DBS in treating tremors to drive market
                                TABLE 139 DEEP BRAIN STIMULATORS MARKET FOR TREMORS, BY REGION, 2021–2029 (USD MILLION)
                                TABLE 140 NORTH AMERICA: DEEP BRAIN STIMULATORS MARKET FOR TREMORS, BY COUNTRY, 2021–2029 (USD MILLION)
                                TABLE 141 EUROPE: DEEP BRAIN STIMULATORS MARKET FOR TREMORS, BY COUNTRY, 2021–2029 (USD MILLION)
                                TABLE 142 ASIA PACIFIC: DEEP BRAIN STIMULATORS MARKET FOR TREMORS, BY COUNTRY, 2021–2029 (USD MILLION)
           8.4.3 DEPRESSION
                    8.4.3.1 Rising research and clinical studies related to depression treatment to propel market
                                TABLE 143 DEEP BRAIN STIMULATORS MARKET FOR DEPRESSION, BY REGION, 2021–2029 (USD MILLION)
                                TABLE 144 NORTH AMERICA: DEEP BRAIN STIMULATORS MARKET FOR DEPRESSION, BY COUNTRY, 2021–2029 (USD MILLION)
                                TABLE 145 EUROPE: DEEP BRAIN STIMULATORS MARKET FOR DEPRESSION, BY COUNTRY, 2021–2029 (USD MILLION)
                                TABLE 146 ASIA PACIFIC: DEEP BRAIN STIMULATORS MARKET FOR DEPRESSION, BY COUNTRY, 2021–2029 (USD MILLION)
           8.4.4 OTHER DBS APPLICATIONS
                    TABLE 147 DEEP BRAIN STIMULATORS MARKET FOR OTHER APPLICATIONS, BY REGION, 2021–2029 (USD MILLION)
                    TABLE 148 NORTH AMERICA: DEEP BRAIN STIMULATORS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2029 (USD MILLION)
                    TABLE 149 EUROPE: DEEP BRAIN STIMULATORS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2029 (USD MILLION)
                    TABLE 150 ASIA PACIFIC: DEEP BRAIN STIMULATORS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2029 (USD MILLION)
    8.5 ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION 
          TABLE 151 BIOELECTRIC MEDICINE MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
           8.5.1 URINE INCONTINENCE
                    8.5.1.1 High incidence of urine incontinence to offer growth opportunities for market players
                                TABLE 152 SACRAL NERVE STIMULATORS MARKET FOR URINE INCONTINENCE, BY REGION, 2021–2029 (USD MILLION)
                                TABLE 153 NORTH AMERICA: SACRAL NERVE STIMULATORS MARKET FOR URINE INCONTINENCE, BY COUNTRY, 2021–2029 (USD MILLION)
                                TABLE 154 EUROPE: SACRAL NERVE STIMULATORS MARKET FOR URINE INCONTINENCE, BY COUNTRY, 2021–2029 (USD MILLION)
                                TABLE 155 ASIA PACIFIC: SACRAL NERVE STIMULATORS MARKET FOR URINE INCONTINENCE, BY COUNTRY, 2021–2029 (USD MILLION)
           8.5.2 FECAL INCONTINENCE
                    8.5.2.1 Reduced symptom recurrence with use of SNS to drive demand
                                TABLE 156 SACRAL NERVE STIMULATORS MARKET FOR FECAL INCONTINENCE, BY REGION, 2021–2029 (USD MILLION)
                                TABLE 157 NORTH AMERICA: SACRAL NERVE STIMULATORS MARKET FOR FECAL INCONTINENCE, BY COUNTRY, 2021–2029 (USD MILLION)
                                TABLE 158 EUROPE: SACRAL NERVE STIMULATORS MARKET FOR FECAL INCONTINENCE, BY COUNTRY, 2021–2029 (USD MILLION)
                                TABLE 159 ASIA PACIFIC: SACRAL NERVE STIMULATORS MARKET FOR FECAL INCONTINENCE, BY COUNTRY, 2021–2029 (USD MILLION)
    8.6 BIOELECTRIC MEDICINE MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION 
          TABLE 160 BIOELECTRIC MEDICINE MARKET FOR VAGUS NERVE SIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
           8.6.1 EPILEPSY
                    8.6.1.1 Advantages associated with VNS in epilepsy treatment to propel market
                                TABLE 161 VAGUS NERVE STIMULATORS MARKET FOR EPILEPSY, BY REGION, 2021–2029 (USD MILLION)
                                TABLE 162 NORTH AMERICA: VAGUS NERVE STIMULATORS MARKET FOR EPILEPSY, BY COUNTRY, 2021–2029 (USD MILLION)
                                TABLE 163 EUROPE: VAGUS NERVE STIMULATORS MARKET FOR EPILEPSY, BY COUNTRY, 2021–2029 (USD MILLION)
                                TABLE 164 ASIA PACIFIC: VAGUS NERVE STIMULATORS MARKET FOR EPILEPSY, BY COUNTRY, 2021–2029 (USD MILLION)
           8.6.2 OTHER VNS APPLICATIONS
                    TABLE 165 VAGUS NERVE STIMULATORS MARKET FOR OTHER APPLICATIONS, BY REGION, 2021–2029 (USD MILLION)
                    TABLE 166 NORTH AMERICA: VAGUS NERVE STIMULATORS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2029 (USD MILLION)
                    TABLE 167 EUROPE: VAGUS NERVE STIMULATORS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2029 (USD MILLION)
                    TABLE 168 ASIA PACIFIC: VAGUS NERVE STIMULATORS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2029 (USD MILLION)
    8.7 ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION 
          TABLE 169 BIOELECTRIC MEDICINE MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
           8.7.1 GASTROPARESIS
                    8.7.1.1 Reduced hospitalization time associated with GES treatment to drive market
                                TABLE 170 GASTRIC ELECTRICAL STIMULATORS MARKET FOR GASTROPARESIS, BY REGION, 2021–2029 (USD MILLION)
                                TABLE 171 NORTH AMERICA: GASTRIC ELECTRICAL STIMULATORS MARKET FOR GASTROPARESIS, BY COUNTRY, 2021–2029 (USD MILLION)
                                TABLE 172 EUROPE: GASTRIC ELECTRICAL STIMULATORS MARKET FOR GASTROPARESIS, BY COUNTRY, 2021–2029 (USD MILLION)
                                TABLE 173 ASIA PACIFIC: GASTRIC ELECTRICAL STIMULATORS MARKET FOR GASTROPARESIS, BY COUNTRY, 2021–2029 (USD MILLION)
           8.7.2 OBESITY
                    8.7.2.1 High prevalence of obesity and risks associated with gastric bypass to propel market
                                TABLE 174 GASTRIC ELECTRICAL STIMULATORS MARKET FOR OBESITY, BY REGION, 2021–2029 (USD MILLION)
                                TABLE 175 NORTH AMERICA: GASTRIC ELECTRICAL STIMULATORS MARKET FOR OBESITY, BY COUNTRY, 2021–2029 (USD MILLION)
                                TABLE 176 EUROPE: GASTRIC ELECTRICAL STIMULATORS MARKET FOR OBESITY, BY COUNTRY, 2021–2029 (USD MILLION)
                                TABLE 177 ASIA PACIFIC: GASTRIC ELECTRICAL STIMULATORS MARKET FOR OBESITY, BY COUNTRY, 2021–2029 (USD MILLION)
    8.8 BIOELECTRIC MEDICINE MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION 
          TABLE 178 BIOELECTRIC MEDICINE MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
           8.8.1 TREATMENT-RESISTANT DEPRESSION
                    8.8.1.1 High prevalence of depression to drive market
                                TABLE 179 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET FOR TREATMENT-RESISTANT DEPRESSION, BY REGION, 2021–2029 (USD MILLION)
                                TABLE 180 NORTH AMERICA: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET FOR TREATMENT-RESISTANT DEPRESSION, BY COUNTRY, 2021–2029 (USD MILLION)
                                TABLE 181 EUROPE: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET FOR TREATMENT-RESISTANT DEPRESSION, BY COUNTRY, 2021–2029 (USD MILLION)
                                TABLE 182 ASIA PACIFIC: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET FOR TREATMENT-RESISTANT DEPRESSION, BY COUNTRY, 2021–2029 (USD MILLION)
           8.8.2 OTHER TENS APPLICATIONS
                    TABLE 183 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET FOR OTHER APPLICATIONS, BY REGION, 2021–2029 (USD MILLION)
                    TABLE 184 NORTH AMERICA: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET FOR OTHER APPLICATIONS, 2021–2029 (USD MILLION)
                    TABLE 185 EUROPE: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2029 (USD MILLION)
                    TABLE 186 ASIA PACIFIC: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2029 (USD MILLION)
    8.9 ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION 
          TABLE 187 BIOELECTRIC MEDICINE MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION
           8.9.1 DEPRESSION
                    8.9.1.1 High effectiveness of TMS and increased acceptance among patients to drive market
                                TABLE 188 TRANSCRANIAL MAGNETIC STIMULATORS MARKET FOR DEPRESSION, BY REGION, 2021–2029 (USD MILLION)
                                TABLE 189 NORTH AMERICA: TRANSCRANIAL MAGNETIC STIMULATORS MARKET FOR DEPRESSION, BY COUNTRY, 2021–2029 (USD MILLION)
                                TABLE 190 EUROPE: TRANSCRANIAL MAGNETIC STIMULATORS MARKET FOR DEPRESSION, BY COUNTRY, 2021–2029 (USD MILLION)
                                TABLE 191 ASIA PACIFIC: TRANSCRANIAL MAGNETIC STIMULATORS MARKET FOR DEPRESSION, BY COUNTRY, 2021–2029 (USD MILLION)
           8.9.2 MIGRAINE
                    8.9.2.1 High prevalence of migraine to support market growth
                                TABLE 192 TRANSCRANIAL MAGNETIC STIMULATORS MARKET FOR MIGRAINE, BY REGION, 2021–2029 (USD MILLION)
                                TABLE 193 NORTH AMERICA: TRANSCRANIAL MAGNETIC STIMULATORS MARKET FOR MIGRAINE, BY COUNTRY, 2021–2029 (USD MILLION)
                                TABLE 194 EUROPE: TRANSCRANIAL MAGNETIC STIMULATORS MARKET FOR MIGRAINE, BY COUNTRY, 2021–2029 (USD MILLION)
                                TABLE 195 ASIA PACIFIC: TRANSCRANIAL MAGNETIC STIMULATORS MARKET FOR MIGRAINE, BY COUNTRY, 2021–2029 (USD MILLION)
    8.10 BIOELECTRIC MEDICINE MARKET FOR RESPIRATORY ELECTRICAL STIMULATORS, BY APPLICATION 
           8.10.1 SPINAL CORD INJURY
                    8.10.1.1 Rising incidence of spinal cord injuries to fuel demand
                                TABLE 196 RESPIRATORY ELECTRICAL STIMULATORS MARKET FOR SPINAL CORD INJURY, BY REGION, 2021–2029 (USD MILLION)
    8.11 ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION 
           TABLE 197 BIOELECTRIC MEDICINE MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION
           8.11.1 ATTENTION-DEFICIT/HYPERACTIVITY DISORDER
                    8.11.1.1 Minimal side effects to drive adoption
                                TABLE 198 TRIGEMINAL NERVE STIMULATORS MARKET FOR ATTENTION-DEFICIT/HYPERACTIVITY DISORDER, BY REGION, 2021–2029 (USD MILLION)
                                TABLE 199 NORTH AMERICA: TRIGEMINAL NERVE STIMULATORS MARKET FOR ATTENTION-DEFICIT/HYPERACTIVITY DISORDER, BY COUNTRY, 2021–2029 (USD MILLION)
                                TABLE 200 EUROPE: TRIGEMINAL NERVE STIMULATORS MARKET FOR ATTENTION-DEFICIT/HYPERACTIVITY DISORDER, BY COUNTRY, 2021–2029 (USD MILLION)
                                TABLE 201 ASIA PACIFIC: TRIGEMINAL NERVE STIMULATORS MARKET FOR ATTENTION-DEFICIT/HYPERACTIVITY DISORDER, BY COUNTRY, 2021–2029 (USD MILLION)
           8.11.2 MIGRAINE
                    8.11.2.1 Increasing demand for non-pharmacological treatments to support market growth
                                TABLE 202 TRIGEMINAL NERVE STIMULATORS MARKET FOR MIGRAINE, BY REGION, 2021–2029 (USD MILLION)
                                TABLE 203 NORTH AMERICA: TRIGEMINAL NERVE STIMULATORS MARKET FOR MIGRAINE, BY COUNTRY, 2021–2029 (USD MILLION)
                                TABLE 204 EUROPE: TRIGEMINAL NERVE STIMULATORS MARKET FOR MIGRAINE, BY COUNTRY, 2021–2029 (USD MILLION)
                                TABLE 205 ASIA PACIFIC: TRIGEMINAL NERVE STIMULATORS MARKET FOR MIGRAINE, BY COUNTRY, 2021–2029 (USD MILLION)
 
9 ELECTROCEUTICALS MARKET, BY REGION (Page No. - 217)
    9.1 INTRODUCTION 
          TABLE 206 ELECTROCEUTICALS MARKET, BY REGION, 2021–2029 (USD MILLION)
    9.2 NORTH AMERICA 
          FIGURE 29 NORTH AMERICA: ELECTROCEUTICALS MARKET SNAPSHOT
          TABLE 207 NORTH AMERICA: MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
          TABLE 208 NORTH AMERICA: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
          TABLE 209 NORTH AMERICA: NEUROMODULATORS MARKET, BY TYPE, 2021–2029 (USD MILLION)
          TABLE 210 NORTH AMERICA: BIOELECTRIC MEDICINE MARKET, BY TYPE, 2021–2029 (USD MILLION)
          TABLE 211 NORTH AMERICA: ELECTROCEUTICALS INDUSTRY FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021–2029 (USD MILLION)
          TABLE 212 NORTH AMERICA: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
          TABLE 213 NORTH AMERICA: MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
          TABLE 214 NORTH AMERICA: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
          TABLE 215 NORTH AMERICA: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
          TABLE 216 NORTH AMERICA: MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
          TABLE 217 NORTH AMERICA: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
          TABLE 218 NORTH AMERICA: ELECTROCEUTICALS INDUSTRY FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
          TABLE 219 NORTH AMERICA: BIOELECTRIC MEDICINE MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
           9.2.1 US
                    9.2.1.1 Rising prevalence of cardiovascular and neurological disorders to drive market
                                TABLE 220 US: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
                                TABLE 221 US: NEUROMODULATORS MARKET, BY TYPE, 2021–2029 (USD MILLION)
                                TABLE 222 US: BIOELECTRIC MEDICINE MARKET, BY TYPE, 2021–2029 (USD MILLION)
                                TABLE 223 US: ELECTROCEUTICALS INDUSTRY FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021–2029 (USD MILLION)
                                TABLE 224 US: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
                                TABLE 225 US: MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
                                TABLE 226 US: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
                                TABLE 227 US: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
                                TABLE 228 US: MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
                                TABLE 229 US: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
                                TABLE 230 US: ELECTROCEUTICALS INDUSTRY FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
                                TABLE 231 US: BIOELECTRIC MEDICINE MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
           9.2.2 CANADA
                    9.2.2.1 Rising healthcare expenditure and increasing prevalence of chronic diseases to drive demand
                                TABLE 232 NEUROLOGICAL CONDITIONS PREVALENT IN CANADA, 2016–2031
                                TABLE 233 CANADA: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
                                TABLE 234 CANADA: NEUROMODULATORS MARKET, BY TYPE, 2021–2029 (USD MILLION)
                                TABLE 235 CANADA: BIOELECTRIC MEDICINE MARKET, BY TYPE, 2021–2029 (USD MILLION)
                                TABLE 236 CANADA: ELECTROCEUTICALS INDUSTRY FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021–2029 (USD MILLION)
                                TABLE 237 CANADA: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
                                TABLE 238 CANADA: MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
                                TABLE 239 CANADA: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
                                TABLE 240 CANADA: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
                                TABLE 241 CANADA: MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
                                TABLE 242 CANADA: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
                                TABLE 243 CANADA: ELECTROCEUTICALS INDUSTRY FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
                                TABLE 244 CANADA: BIOELECTRIC MEDICINE MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
           9.2.3 NORTH AMERICA: RECESSION IMPACT
    9.3 EUROPE 
          TABLE 245 EUROPE: ELECTROCEUTICALS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
          TABLE 246 EUROPE: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
          TABLE 247 EUROPE: NEUROMODULATORS MARKET, BY TYPE, 2021–2029 (USD MILLION)
          TABLE 248 EUROPE: BIOELECTRIC MEDICINE MARKET, BY TYPE, 2021–2029 (USD MILLION)
          TABLE 249 EUROPE: ELECTROCEUTICALS INDUSTRY FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021–2029 (USD MILLION)
          TABLE 250 EUROPE: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
          TABLE 251 EUROPE: MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
          TABLE 252 EUROPE: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
          TABLE 253 EUROPE: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
          TABLE 254 EUROPE: MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
          TABLE 255 EUROPE: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
          TABLE 256 EUROPE: ELECTROCEUTICALS INDUSTRY FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
          TABLE 257 EUROPE: BIOELECTRIC MEDICINE MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
           9.3.1 GERMANY
                    9.3.1.1 Presence of favorable reimbursement policies to drive market
                                TABLE 258 GERMANY: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
                                TABLE 259 GERMANY: NEUROMODULATORS MARKET, BY TYPE, 2021–2029 (USD MILLION)
                                TABLE 260 GERMANY: BIOELECTRIC MEDICINE MARKET, BY TYPE, 2021–2029 (USD MILLION)
                                TABLE 261 GERMANY: ELECTROCEUTICALS INDUSTRY FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021–2029 (USD MILLION)
                                TABLE 262 GERMANY: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
                                TABLE 263 GERMANY: MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
                                TABLE 264 GERMANY: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
                                TABLE 265 GERMANY: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
                                TABLE 266 GERMANY: MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
                                TABLE 267 GERMANY: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
                                TABLE 268 GERMANY: ELECTROCEUTICALS INDUSTRY FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
                                TABLE 269 GERMANY: BIOELECTRIC MEDICINE MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
           9.3.2 UK
                    9.3.2.1 Rising support from government and private organizations to fuel market growth
                                TABLE 270 UK: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
                                TABLE 271 UK: NEUROMODULATORS MARKET, BY TYPE, 2021–2029 (USD MILLION)
                                TABLE 272 UK: BIOELECTRIC MEDICINE MARKET, BY TYPE, 2021–2029 (USD MILLION)
                                TABLE 273 UK: ELECTROCEUTICALS INDUSTRY FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021–2029 (USD MILLION)
                                TABLE 274 UK: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
                                TABLE 275 UK: MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
                                TABLE 276 UK: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
                                TABLE 277 UK: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
                                TABLE 278 UK: MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
                                TABLE 279 UK: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
                                TABLE 280 UK: ELECTROCEUTICALS INDUSTRY FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
                                TABLE 281 UK: BIOELECTRIC MEDICINE MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
           9.3.3 FRANCE
                    9.3.3.1 Promising healthcare reforms to drive market
                                TABLE 282 FRANCE: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
                                TABLE 283 FRANCE: NEUROMODULATORS MARKET, BY TYPE, 2021–2029 (USD MILLION)
                                TABLE 284 FRANCE: BIOELECTRIC MEDICINE MARKET, BY TYPE, 2021–2029 (USD MILLION)
                                TABLE 285 FRANCE: ELECTROCEUTICALS INDUSTRY FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021–2029 (USD MILLION)
                                TABLE 286 FRANCE: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
                                TABLE 287 FRANCE: MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
                                TABLE 288 FRANCE: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
                                TABLE 289 FRANCE: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
                                TABLE 290 FRANCE: MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
                                TABLE 291 FRANCE: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
                                TABLE 292 FRANCE: ELECTROCEUTICALS INDUSTRY FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
                                TABLE 293 FRANCE: BIOELECTRIC MEDICINE MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
           9.3.4 ITALY
                    9.3.4.1 Easy access to healthcare services to create lucrative opportunities for market growth
                                TABLE 294 ITALY: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
                                TABLE 295 ITALY: NEUROMODULATORS MARKET, BY TYPE, 2021–2029 (USD MILLION)
                                TABLE 296 ITALY: BIOELECTRIC MEDICINE MARKET, BY TYPE, 2021–2029 (USD MILLION)
                                TABLE 297 ITALY: ELECTROCEUTICALS INDUSTRY FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021–2029 (USD MILLION)
                                TABLE 298 ITALY: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
                                TABLE 299 ITALY: ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
                                TABLE 300 ITALY: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
                                TABLE 301 ITALY: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
                                TABLE 302 ITALY: ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
                                TABLE 303 ITALY: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
                                TABLE 304 ITALY: ELECTROCEUTICALS INDUSTRY FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
                                TABLE 305 ITALY: BIOELECTRIC MEDICINE MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
           9.3.5 SPAIN
                    9.3.5.1 Increasing number of conferences and awareness programs to support market growth
                                TABLE 306 SPAIN: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
                                TABLE 307 SPAIN: NEUROMODULATORS MARKET, BY TYPE, 2021–2029 (USD MILLION)
                                TABLE 308 SPAIN: BIOELECTRIC MEDICINE MARKET, BY TYPE, 2021–2029 (USD MILLION)
                                TABLE 309 SPAIN: ELECTROCEUTICALS INDUSTRY FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021–2029 (USD MILLION)
                                TABLE 310 SPAIN: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
                                TABLE 311 SPAIN: MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
                                TABLE 312 SPAIN: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
                                TABLE 313 SPAIN: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
                                TABLE 314 SPAIN: MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
                                TABLE 315 SPAIN: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
                                TABLE 316 SPAIN: ELECTROCEUTICALS INDUSTRY FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
                                TABLE 317 SPAIN: BIOELECTRIC MEDICINE MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
           9.3.6 REST OF EUROPE
                    TABLE 318 REST OF EUROPE: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
                    TABLE 319 REST OF EUROPE: NEUROMODULATORS MARKET, BY TYPE, 2021–2029 (USD MILLION)
                    TABLE 320 REST OF EUROPE: ELECTROCEUTICALS INDUSTRY , BY TYPE, 2021–2029 (USD MILLION)
                    TABLE 321 REST OF EUROPE: ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021–2029 (USD MILLION)
                    TABLE 322 REST OF EUROPE: BIOELECTRIC MEDICINE MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
                    TABLE 323 REST OF EUROPE: ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
                    TABLE 324 REST OF EUROPE: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
                    TABLE 325 REST OF EUROPE: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
                    TABLE 326 REST OF EUROPE: ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
                    TABLE 327 REST OF EUROPE: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
                    TABLE 328 REST OF EUROPE: ELECTROCEUTICALS INDUSTRY FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
                    TABLE 329 REST OF EUROPE: BIOELECTRIC MEDICINE MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
           9.3.7 EUROPE: RECESSION IMPACT
    9.4 ASIA PACIFIC 
          FIGURE 30 ASIA PACIFIC: ELECTROCEUTICALS MARKET SNAPSHOT
          TABLE 330 ASIA PACIFIC: MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
          TABLE 331 ASIA PACIFIC: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
          TABLE 332 ASIA PACIFIC: NEUROMODULATORS MARKET, BY TYPE, 2021–2029 (USD MILLION)
          TABLE 333 ASIA PACIFIC: BIOELECTRIC MEDICINE MARKET, BY TYPE, 2021–2029 (USD MILLION)
          TABLE 334 ASIA PACIFIC: ELECTROCEUTICALS INDUSTRY FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021–2029 (USD MILLION)
          TABLE 335 ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
          TABLE 336 ASIA PACIFIC: MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
          TABLE 337 ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
          TABLE 338 ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
          TABLE 339 ASIA PACIFIC: MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
          TABLE 340 ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
          TABLE 341 ASIA PACIFIC: ELECTROCEUTICALS INDUSTRY FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
          TABLE 342 ASIA PACIFIC: BIOELECTRIC MEDICINE MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
           9.4.1 JAPAN
                    9.4.1.1 Increasing prevalence of cardiovascular and neurological disorders to drive demand
                                TABLE 343 JAPAN: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
                                TABLE 344 JAPAN: NEUROMODULATORS MARKET, BY TYPE, 2021–2029 (USD MILLION)
                                TABLE 345 JAPAN: BIOELECTRIC MEDICINE MARKET, BY TYPE, 2021–2029 (USD MILLION)
                                TABLE 346 JAPAN: ELECTROCEUTICALS INDUSTRY FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021–2029 (USD MILLION)
                                TABLE 347 JAPAN: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
                                TABLE 348 JAPAN: MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
                                TABLE 349 JAPAN: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
                                TABLE 350 JAPAN: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
                                TABLE 351 JAPAN: MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
                                TABLE 352 JAPAN: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
                                TABLE 353 JAPAN: ELECTROCEUTICALS INDUSTRY FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
                                TABLE 354 JAPAN: BIOELECTRIC MEDICINE MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
           9.4.2 CHINA
                    9.4.2.1 Rising geriatric population to support market growth
                                TABLE 355 CHINA: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
                                TABLE 356 CHINA: NEUROMODULATORS MARKET, BY TYPE, 2021–2029 (USD MILLION)
                                TABLE 357 CHINA: BIOELECTRIC MEDICINE MARKET, BY TYPE, 2021–2029 (USD MILLION)
                                TABLE 358 CHINA: ELECTROCEUTICALS INDUSTRY FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021–2029 (USD MILLION)
                                TABLE 359 CHINA: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
                                TABLE 360 CHINA: ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
                                TABLE 361 CHINA: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
                                TABLE 362 CHINA: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
                                TABLE 363 CHINA: ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
                                TABLE 364 CHINA: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
                                TABLE 365 CHINA: ELECTROCEUTICALS INDUSTRY FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
                                TABLE 366 CHINA: BIOELECTRIC MEDICINE MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
           9.4.3 INDIA
                    9.4.3.1 Developments in healthcare structure to propel market
                                TABLE 367 INDIA: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
                                TABLE 368 INDIA: NEUROMODULATORS MARKET, BY TYPE, 2021–2029 (USD MILLION)
                                TABLE 369 INDIA: BIOELECTRIC MEDICINE MARKET, BY TYPE, 2021–2029 (USD MILLION)
                                TABLE 370 INDIA: ELECTROCEUTICALS INDUSTRY FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021–2029 (USD MILLION)
                                TABLE 371 INDIA: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
                                TABLE 372 INDIA: MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
                                TABLE 373 INDIA: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
                                TABLE 374 INDIA: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
                                TABLE 375 INDIA: MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
                                TABLE 376 INDIA: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
                                TABLE 377 INDIA: ELECTROCEUTICALS INDUSTRY FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
                                TABLE 378 INDIA: BIOELECTRIC MEDICINE MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
           9.4.4 REST OF ASIA PACIFIC
                    TABLE 379 REST OF ASIA PACIFIC: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
                    TABLE 380 REST OF ASIA PACIFIC: NEUROMODULATORS MARKET, BY TYPE, 2021–2029 (USD MILLION)
                    TABLE 381 REST OF ASIA PACIFIC: BIOELECTRIC MEDICINE MARKET, BY TYPE, 2021–2029 (USD MILLION)
                    TABLE 382 REST OF ASIA PACIFIC: ELECTROCEUTICALS INDUSTRY FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021–2029 (USD MILLION)
                    TABLE 383 REST OF ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
                    TABLE 384 REST OF ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
                    TABLE 385 REST OF ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
                    TABLE 386 REST OF ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
                    TABLE 387 REST OF ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
                    TABLE 388 REST OF ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
                    TABLE 389 REST OF ASIA PACIFIC: ELECTROCEUTICALS INDUSTRY FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
                    TABLE 390 REST OF ASIA PACIFIC: BIOELECTRIC MEDICINE MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
           9.4.5 ASIA PACIFIC: RECESSION IMPACT
    9.5 LATIN AMERICA 
           9.5.1 RAPIDLY GROWING GERIATRIC POPULATION TO SUPPORT MARKET GROWTH
                    TABLE 391 LATIN AMERICA: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
                    TABLE 392 LATIN AMERICA: NEUROMODULATORS MARKET, BY TYPE, 2021–2029 (USD MILLION)
                    TABLE 393 LATIN AMERICA: BIOELECTRIC MEDICINE MARKET, BY TYPE, 2021–2029 (USD MILLION)
                    TABLE 394 LATIN AMERICA: ELECTROCEUTICALS INDUSTRY FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021–2029 (USD MILLION)
                    TABLE 395 LATIN AMERICA: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
                    TABLE 396 LATIN AMERICA: MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
                    TABLE 397 LATIN AMERICA: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
                    TABLE 398 LATIN AMERICA: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
                    TABLE 399 LATIN AMERICA: MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
                    TABLE 400 LATIN AMERICA: ELECTROCEUTICALS INDUSTRY FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
                    TABLE 401 LATIN AMERICA: BIOELECTRIC MEDICINE MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
                    TABLE 402 LATIN AMERICA: ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
           9.5.2 LATIN AMERICA: RECESSION IMPACT
    9.6 MIDDLE EAST & AFRICA 
          TABLE 403 MIDDLE EAST & AFRICA: ELECTROCEUTICALS MARKET, BY REGION, 2021–2029 (USD MILLION)
          TABLE 404 MIDDLE EAST & AFRICA: BIOELECTRIC MEDICINE MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
          TABLE 405 MIDDLE EAST & AFRICA: NEUROMODULATORS MARKET, BY TYPE, 2021–2029 (USD MILLION)
          TABLE 406 MIDDLE EAST & AFRICA: ELECTROCEUTICALS INDUSTRY , BY TYPE, 2021–2029 (USD MILLION)
          TABLE 407 MIDDLE EAST & AFRICA: MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021–2029 (USD MILLION)
          TABLE 408 MIDDLE EAST & AFRICA: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
          TABLE 409 MIDDLE EAST & AFRICA: MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
          TABLE 410 MIDDLE EAST & AFRICA: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
          TABLE 411 MIDDLE EAST & AFRICA: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
          TABLE 412 MIDDLE EAST & AFRICA: MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
          TABLE 413 MIDDLE EAST & AFRICA: ELECTROCEUTICALS INDUSTRY FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
          TABLE 414 MIDDLE EAST & AFRICA: BIOELECTRIC MEDICINE MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
          TABLE 415 MIDDLE EAST & AFRICA: ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
           9.6.1 GCC COUNTRIES
                    9.6.1.1 Advances in healthcare sector to support market growth
                                TABLE 416 GCC COUNTRIES: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
                                TABLE 417 GCC COUNTRIES: NEUROMODULATORS MARKET, BY TYPE, 2021–2029 (USD MILLION)
                                TABLE 418 GCC COUNTRIES: BIOELECTRIC MEDICINE MARKET, BY TYPE, 2021–2029 (USD MILLION)
           9.6.2 REST OF MIDDLE EAST & AFRICA
                    TABLE 419 REST OF MIDDLE EAST & AFRICA: ELECTROCEUTICALS INDUSTRY, BY PRODUCT, 2021–2029 (USD MILLION)
                    TABLE 420 REST OF MIDDLE EAST & AFRICA: NEUROMODULATORS MARKET, BY TYPE, 2021–2029 (USD MILLION)
                    TABLE 421 REST OF MIDDLE EAST & AFRICA: BIOELECTRIC MEDICINE MARKET, BY TYPE, 2021–2029 (USD MILLION)
           9.6.3 MIDDLE EAST & AFRICA: RECESSION IMPACT
 
10 COMPETITIVE LANDSCAPE (Page No. - 326)
     10.1 OVERVIEW 
     10.2 STRATEGIES ADOPTED BY KEY PLAYERS/RIGHT TO WIN 
             TABLE 422 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS
     10.3 REVENUE ANALYSIS 
             FIGURE 31 REVENUE ANALYSIS OF KEY PLAYERS IN ELECTROCEUTICALS MARKET
     10.4 MARKET SHARE ANALYSIS 
             TABLE 423 ELECTROCEUTICALS INDUSTRY: DEGREE OF COMPETITION
     10.5 BRAND/PRODUCT COMPARISON 
             FIGURE 32 ELECTROCEUTICALS INDUSTRY: BRAND COMPARISON, BY KEY PLAYER
     10.6 COMPANY EVALUATION MATRIX: KEY PLAYERS 
             10.6.1 STARS
             10.6.2 EMERGING LEADERS
             10.6.3 PERVASIVE PLAYERS
             10.6.4 PARTICIPANTS
                        FIGURE 33 BIOELECTRIC MEDICINE MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2022
     10.7 COMPANY FOOTPRINT 
             TABLE 424 PRODUCT FOOTPRINT
             TABLE 425 REGIONAL FOOTPRINT
             TABLE 426 OVERALL COMPANY FOOTPRINT
     10.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES 
             10.8.1 PROGRESSIVE COMPANIES
             10.8.2 STARTING BLOCKS
             10.8.3 RESPONSIVE COMPANIES
             10.8.4 DYNAMIC COMPANIES
                        FIGURE 34 BIOELECTRIC MEDICINE MARKET: COMPANY EVALUATION MATRIX (STARTUPS/ SMES), 2022
     10.9 COMPETITIVE BENCHMARKING 
             TABLE 427 BIOELECTRIC MEDICINE MARKET: DETAILED LIST OF KEY STARTUPS/SMES
             TABLE 428 PRODUCT FOOTPRINT (STARTUPS/SMES)
             TABLE 429 REGIONAL FOOTPRINT (STARTUPS/SMES)
             TABLE 430 OVERALL COMPANY FOOTPRINT (STARTUPS/SMES)
     10.1 COMPETITIVE SCENARIO 
             10.10.1 PRODUCT LAUNCHES & APPROVALS
                        TABLE 431 PRODUCT LAUNCHES & APPROVALS
             10.10.2 DEALS
                        TABLE 432 DEALS
 
11 COMPANY PROFILES (Page No. - 341)
(Business Overview, Products/Solutions/Services Offered, Recent Developments, MnM view (Key strengths/Right to win, Strategic choices made, Weakness/competitive threats)*
     11.1 KEY PLAYERS 
             11.1.1 MEDTRONIC
                        TABLE 433 MEDTRONIC: BUSINESS OVERVIEW
                        FIGURE 35 MEDTRONIC: COMPANY SNAPSHOT (2023)
             11.1.2 BOSTON SCIENTIFIC CORPORATION
                        TABLE 434 BOSTON SCIENTIFIC CORPORATION: BUSINESS OVERVIEW
                        FIGURE 36 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2022)
             11.1.3 ABBOTT
                        TABLE 435 ABBOTT: BUSINESS OVERVIEW
                        FIGURE 37 ABBOTT: COMPANY SNAPSHOT (2022)
             11.1.4 LIVANOVA PLC
                        TABLE 436 LIVANOVA PLC: BUSINESS OVERVIEW
                        FIGURE 38 LIVANOVA PLC: COMPANY SNAPSHOT (2022)
             11.1.5 COCHLEAR LTD.
                        TABLE 437 COCHLEAR LTD.: BUSINESS OVERVIEW
                        FIGURE 39 COCHLEAR LTD.: COMPANY SNAPSHOT (2023)
             11.1.6 MICROPORT SCIENTIFIC CORPORATION
                        TABLE 438 MICROPORT SCIENTIFIC CORPORATION: BUSINESS OVERVIEW
                        FIGURE 40 MICROPORT SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2022)
             11.1.7 SONOVA
                        TABLE 439 SONOVA: BUSINESS OVERVIEW
                        FIGURE 41 SONOVA GROUP: COMPANY SNAPSHOT (2022)
             11.1.8 NEVRO CORP.
                        TABLE 440 NEVRO CORP.: BUSINESS OVERVIEW
                        FIGURE 42 NEVRO CORP.: COMPANY SNAPSHOT (2022)
             11.1.9 AXONICS, INC.
                        TABLE 441 AXONICS, INC.: BUSINESS OVERVIEW
                        FIGURE 43 AXONICS INC.: COMPANY SNAPSHOT (2022)
             11.1.10 NEURONETICS
                        TABLE 442 NEURONETICS: BUSINESS OVERVIEW
                        FIGURE 44 NEURONETICS: COMPANY SNAPSHOT (2022)
             11.1.11 ELECTROCORE, INC.
                        TABLE 443 ELECTROCORE, INC.: BUSINESS OVERVIEW
                        FIGURE 45 ELECTROCORE, INC.: COMPANY SNAPSHOT (2022)
             11.1.12 NEUROPACE, INC.
                        TABLE 444 NEUROPACE, INC.: BUSINESS OVERVIEW
                        FIGURE 46 NEUROPACE, INC.: COMPANY SNAPSHOT (2022)
     11.2 OTHER PLAYERS 
             11.2.1 BIOTRONIK
                        TABLE 445 BIOTRONIK: COMPANY OVERVIEW
             11.2.2 MEDICO S.R.L.
                        TABLE 446 MEDICO S.R.L.: COMPANY OVERVIEW
             11.2.3 ZHEJIANG NUROTRON BIOTECHNOLOGY CO., LTD.
                        TABLE 447 ZHEJIANG NUROTRON BIOTECHNOLOGY CO., LTD.: COMPANY OVERVIEW
             11.2.4 MED-EL
                        TABLE 448 MED-EL: COMPANY OVERVIEW
             11.2.5 ALEVA NEUROTHERAPEUTICS
                        TABLE 449 ALEVA NEUROTHERAPEUTICS: COMPANY OVERVIEW
             11.2.6 NEUROSIGMA, INC.
                        TABLE 450 NEUROSIGMA, INC.: COMPANY OVERVIEW
             11.2.7 BIOWAVE CORPORATION
                        TABLE 451 BIOWAVE CORPORATION: COMPANY OVERVIEW
             11.2.8 SOTERIX MEDICAL INC.
                        TABLE 452 SOTERIX MEDICAL INC.: COMPANY OVERVIEW
             11.2.9 BIOINDUCTION (AMBER THERAPEUTICS)
                        TABLE 453 BIOINDUCTION (AMBER THERAPEUTICS): COMPANY OVERVIEW
             11.2.10 GIMER MEDICAL
                        TABLE 454 GIMER MEDICAL: COMPANY OVERVIEW
             11.2.11 CEFALY
                        TABLE 455 CEFALY: COMPANY OVERVIEW
             11.2.12 BIOCONTROL MEDICAL
                        TABLE 456 BIOCONTROL MEDICAL: COMPANY OVERVIEW
             11.2.13 TVNS HEALTH GMBH
                        TABLE 457 TVNS HEALTH GMBH: COMPANY OVERVIEW
 
*Details on Business Overview, Products/Solutions/Services Offered, Recent Developments, MnM view (Key strengths/Right to win, Strategic choices made, Weakness/competitive threats)* might not be captured in case of unlisted companies.
 
12 APPENDIX (Page No. - 391)
     12.1 DISCUSSION GUIDE 
     12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 
     12.3 CUSTOMIZATION OPTIONS 
     12.4 RELATED REPORTS 
     12.5 AUTHOR DETAILS 

This study involved four major activities in estimating the current size of the electroceuticals market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate segments and subsegments' market size.

The objective of the study is to analyze the key market dynamics, such as drivers, opportunities, challenges, restraints, and key player strategies. To track company developments such as acquisitions, product launches, expansions, collaborations, agreements, and partnerships of the leading players, the competitive landscape of the electroceuticals market to analyze market players on various parameters within the broad categories of business and product strategy. Top-down and bottom-up approaches were used to estimate the market size. To estimate the market size of segments and subsegments, market breakdown and data triangulation were used.

The four steps involved in estimating the market size are:

Collecting Secondary Data

The secondary research data collection process involves the usage of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B), annual reports, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the electroceuticals market. A database of the key industry leaders was also prepared using secondary research.

Collecting Primary Data

The primary research data was conducted after acquiring knowledge about the electroceuticals market scenario through secondary research. A significant number of primary interviews were conducted with stakeholders from both the demand side (such as hospitals, clinics and ambulatory surgery centers (ASCs)) and supply side (such as included various industry experts, such as Directors, Chief X Officers (CXOs), Vice Presidents (VPs) from business development, marketing and product development teams, product manufacturers, wholesalers, channel partners, and distributors) across major countries of North America, Europe, Asia Pacific, the Middle East & Africa, and Latin America. Approximately 40% of the primary interviews were conducted with stakeholders from the demand side, while those from the supply side accounted for the remaining 60%. Primary data for this report was collected through questionnaires, emails, and telephonic interviews.

A breakdown of the primary respondents is provided below:

The following is a breakdown of the primary respondents

Electroceuticals  Market Size, and Share

Note 1: *Others include sales managers, marketing managers, and product managers.

Note 2: Tiers are defined based on a company’s total revenue as of 2023: Tier 1=> USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3=< USD 500 million.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

All major product manufacturers offering various electroceuticals products were identified at the global/regional level. Revenue mapping was done for the major players and was extrapolated to arrive at the global market value of each type of segment. The market value electroceuticals market was also split into various segments and subsegments at the region and country level based on:

  • Product mapping of various manufacturers for each type of electroceuticals market at the regional and country-level  
  • Relative adoption pattern of each electroceuticals market among key application segments at the regional and/or country-level   
  • Detailed primary research to gather qualitative and quantitative information related to segments and subsegments at the regional and/or country-level. 
  • Detailed secondary research to gauge the prevailing market trends at the regional and/or country-level 

Global Electroceuticals Market Size: Top-Down Approach

Electroceuticals  Market Size, and Share

To know about the assumptions considered for the study, Request for Free Sample Report

Data Triangulation

After arriving at the overall market size applying the process mentioned above, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the electroceuticals device industry.

Market Definition

Electroceuticals are medical devices that use electrical impulses to modulate the body’s neural circuits as an alternative to drug-based intervention. Electroceuticals, also known as bioelectric medicine, combines molecular medicine, bioengineering, and neuroscience to discover and develop nerve stimulating & sensing technologies to regulate biological processes and treat diseases.

Key Stakeholders

  • Manufacturing Companies of Electroceuticals and Related Devices
  • Original Equipment Manufacturers
  • Suppliers and Distributors of Electroceutical Devices
  • Healthcare Service Providers
  • Teaching Hospitals and Academic Medical Centers (AMCs)
  • Health Insurance Payers
  • Research and Consulting Firms
  • Medical Research Institutes
  • Healthcare Institutes/Providers (Hospitals, Medical Groups, Physicians’ Practices, Diagnostic Centers, and Outpatient Clinics)
  • Venture Capitalists
  • Community Centers

Report Objectives

  • To define, describe, segment, and forecast the global electroceuticals market by product, type, application, and region
  • To forecast the size of the global electroceuticals market with respect to five regional segments, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa
  • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
  • To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall electroceuticals market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To profile the key players in the electroceuticals market and comprehensively analyze their market shares and core competencies2 in terms of market developments and growth strategies
  • To track and analyze competitive developments such as product launches, agreements, collaborations, partnerships, expansions, and acquisitions in the electroceuticals market
  • To benchmark players within the electroceuticals market using the Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business strategy, market share, and product offerings

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report:

Country Information

  • Electroceuticals market size and growth rate estimates for countries in the Rest of Europe, the Rest of Asia Pacific, Latin America, and Middle East & Africa.

Company profiles

  • Product portfolio matrix for leading market players.
Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Request Customization

Instant Answers with GPT - Ask Now!

Ask real questions. Get complete answers !
Report Code
MD 4358
Published ON
Mar, 2024
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Electroceuticals Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2024 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status Website Feedback